We at ingineeon develop the tools to form an unbeatable alliance with the most precise, efficacious and lasting force against diseases: our immune system.

With our cytokine-based immunotherapeutics we can precisely modulate immune responses. This will allow for a therapeutic breakthrough in immuno-oncology, infectious diseases and autoimmunity. Our pipeline comprises immunotherapeutics that can (i) restore immune functions, (ii) precisely dampen immune responses or (iii) (re-) activate immune reactions. In addition, we also have a cytokine-based platform technology for advanced cell therapies. As a spin-off from the Technical University of Munich, our goal is to become a clinical stage company in the coming few years.